Keshavarzian A - Search Results

1

New molecular insights into inflammatory bowel disease-induced diarrhea.

Tang Y, Forsyth CB, Keshavarzian A. Tang Y, et al. Among authors: keshavarzian a. Expert Rev Gastroenterol Hepatol. 2011 Oct;5(5):615-25. doi: 10.1586/egh.11.64. Expert Rev Gastroenterol Hepatol. 2011. PMID: 21910579 Free PMC article. Review.

2

New developments in the treatment of inflammatory bowel disease.

Mutlu EA, Farhadi A, Keshavarzian A. Mutlu EA, et al. Among authors: keshavarzian a. Expert Opin Investig Drugs. 2002 Mar;11(3):365-85. doi: 10.1517/13543784.11.3.365. Expert Opin Investig Drugs. 2002. PMID: 11866666 Review.

3

Intestinal barrier: an interface between health and disease.

Farhadi A, Banan A, Fields J, Keshavarzian A. Farhadi A, et al. Among authors: keshavarzian a. J Gastroenterol Hepatol. 2003 May;18(5):479-97. doi: 10.1046/j.1440-1746.2003.03032.x. J Gastroenterol Hepatol. 2003. PMID: 12702039 Review.

4

Critical role of the atypical {lambda} isoform of protein kinase C (PKC-{lambda}) in oxidant-induced disruption of the microtubule cytoskeleton and barrier function of intestinal epithelium.

Banan A, Zhang LJ, Farhadi A, Fields JZ, Shaikh M, Forsyth CB, Choudhary S, Keshavarzian A. Banan A, et al. Among authors: keshavarzian a. J Pharmacol Exp Ther. 2005 Feb;312(2):458-71. doi: 10.1124/jpet.104.074591. Epub 2004 Sep 3. J Pharmacol Exp Ther. 2005. PMID: 15347733

5

theta Isoform of protein kinase C alters barrier function in intestinal epithelium through modulation of distinct claudin isotypes: a novel mechanism for regulation of permeability.

Banan A, Zhang LJ, Shaikh M, Fields JZ, Choudhary S, Forsyth CB, Farhadi A, Keshavarzian A. Banan A, et al. Among authors: keshavarzian a. J Pharmacol Exp Ther. 2005 Jun;313(3):962-82. doi: 10.1124/jpet.104.083428. J Pharmacol Exp Ther. 2005. PMID: 15900076

6

Heightened responses to stressors in patients with inflammatory bowel disease.

Farhadi A, Keshavarzian A, Van de Kar LD, Jakate S, Domm A, Zhang L, Shaikh M, Banan A, Fields JZ. Farhadi A, et al. Among authors: keshavarzian a. Am J Gastroenterol. 2005 Aug;100(8):1796-804. doi: 10.1111/j.1572-0241.2005.50071.x. Am J Gastroenterol. 2005. PMID: 16086717

7

Regulation of oxidant-induced intestinal permeability by metalloprotease-dependent epidermal growth factor receptor signaling.

Forsyth CB, Banan A, Farhadi A, Fields JZ, Tang Y, Shaikh M, Zhang LJ, Engen PA, Keshavarzian A. Forsyth CB, et al. Among authors: keshavarzian a. J Pharmacol Exp Ther. 2007 Apr;321(1):84-97. doi: 10.1124/jpet.106.113019. Epub 2007 Jan 12. J Pharmacol Exp Ther. 2007. PMID: 17220428

8

Evidence for non-chemical, non-electrical intercellular signaling in intestinal epithelial cells.

Farhadi A, Forsyth C, Banan A, Shaikh M, Engen P, Fields JZ, Keshavarzian A. Farhadi A, et al. Among authors: keshavarzian a. Bioelectrochemistry. 2007 Nov;71(2):142-8. doi: 10.1016/j.bioelechem.2007.03.001. Epub 2007 Mar 12. Bioelectrochemistry. 2007. PMID: 17428745

9

An initial report of sleep disturbance in inactive inflammatory bowel disease.

Keefer L, Stepanski EJ, Ranjbaran Z, Benson LM, Keshavarzian A. Keefer L, et al. Among authors: keshavarzian a. J Clin Sleep Med. 2006 Oct 15;2(4):409-16. J Clin Sleep Med. 2006. PMID: 17557469

10

Reduced immunostaining for c-kit receptors in mucosal mast cells in inflammatory bowel disease.

Farhadi A, Keshavarzian A, Fields JZ, Jakate S, Shaikh M, Banan A. Farhadi A, et al. Among authors: keshavarzian a. J Gastroenterol Hepatol. 2007 Dec;22(12):2338-43. doi: 10.1111/j.1440-1746.2007.05011.x. Epub 2007 Jul 20. J Gastroenterol Hepatol. 2007. PMID: 17645464

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

433 results

Search Page

Filters